Medpace is a global full-service clinical research (CRO) providing Phase I-IV core development services for drug, biologic and device programs. Medpace has strong experience supporting development programs across a number of therapeutic areas including oncology, cardiovascular, metabolic/diabetes, infectious disease, neuroscience, regenerative medicine, gastrointestinal diseases, pediatrics and orphan disease. With extensive medical expertise and renowned regulatory affair department, Medpace employs over 2400 employees and has clinical trial experience that spans six continents. From feasibility, research site compatibility, safety and logistics, medpace brings efficiencies and operational excellence to both drug and device development programs. in addition, Medpace offers integrated imagining central and bioanalytical lab capabilities and clinical pharmacology through wholly- owned business units to provide cohesive, streamlined and standardized trial management.
Medpace at the Diabetes Walk
Medpace in action at the Heart Mini
Medpace Corporate Headquarters
Recognizing Rare Disease Day
Every day is different.
I have the opportunity to do something different every day.
I love the people around me, and feeling trusted to do my best.
The company has amazing people in every department, and they treat their employees the best.